Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion type Assertion NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_head.
- NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion description "[The siRNA-mediated depletion of the p53 targets p21, BAX, or PUMA reduced the neuroblastoma cell sensitivity to flubendazole with PUMA depletion resulting in the most pronounced effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_provenance.
- NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion evidence source_evidence_literature NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_provenance.
- NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion SIO_000772 25644037 NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_provenance.
- NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion wasDerivedFrom befree-2016 NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_provenance.
- NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_assertion wasGeneratedBy ECO_0000203 NP1260298.RArr8VRXxobHNjeYGwz0ugVavdPW-ZU3XtmC_486lADaM130_provenance.